612 related articles for article (PubMed ID: 6253714)
1. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
2. Immune response to leukemia virus and tumor-associated antigens in cats.
Essex M; Sliski A; Hardy WD; Cotter SM
Cancer Res; 1976 Feb; 36(2 pt 2):640-5. PubMed ID: 56224
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus.
Olsen RG; Hoover EA; Schaller JP; Mathes LE; Wolff LH
Cancer Res; 1977 Jul; 37(7 Pt 1):2082-5. PubMed ID: 67886
[TBL] [Abstract][Full Text] [Related]
4. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines.
Pedersen NC; Theilen GH; Werner LL
Am J Vet Res; 1979 Aug; 40(8):1120-6. PubMed ID: 230767
[TBL] [Abstract][Full Text] [Related]
6. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
7. Immunization against feline oncarnavirus disease using a killed tumor cell vaccine.
Olsen RG; Hoover EA; Mathes LE; Heding L; Schaller JP
Cancer Res; 1976 Oct; 36(10):3642-6. PubMed ID: 182360
[TBL] [Abstract][Full Text] [Related]
8. Feline oncornavirus-associated cell membrane antigen: a viral and not a cellularly coded transformation-specific antigen of cat lymphomas.
Vedbrat SS; Rasheed S; Lutz H; Gonda MA; Ruscetti S; Gardner MB; Prensky W
Virology; 1983 Jan; 124(2):445-61. PubMed ID: 6186079
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
[TBL] [Abstract][Full Text] [Related]
10. Experimental oncornavirus vaccines in the cat.
Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
[TBL] [Abstract][Full Text] [Related]
11. [Feline leukemogenic and sarcomatogenic viruses].
Parodi AL
C R Seances Soc Biol Fil; 1975; 169(3 Suppl):794-806. PubMed ID: 175893
[TBL] [Abstract][Full Text] [Related]
12. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against feline leukaemia virus using a cell membrane antigen system.
Jarrett W; Jarrett O; Mackey L; Laird H; Hood C; Hay D
Int J Cancer; 1975 Jul; 16(1):134-41. PubMed ID: 170211
[TBL] [Abstract][Full Text] [Related]
14. Feline leukemia - unique and cross-relating antigens on individual virus-producing tumors identified by complement-dependent antibody.
Grant CK; Michalek MT
Int J Cancer; 1981 Aug; 28(2):209-17. PubMed ID: 6172390
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus.
Swenson CL; Kociba GJ; Mathes LE; Hand PJ; Neer CA; Hayes KA; Olsen RG
J Am Vet Med Assoc; 1990 Apr; 196(7):1049-52. PubMed ID: 2158493
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
Hines DL; Cutting JA; Dietrich DL; Walsh JA
J Am Vet Med Assoc; 1991 Nov; 199(10):1428-30. PubMed ID: 1666097
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
18. Feline cytotoxic immune mechanisms against virus-associated leukemia and fibrosarcoma.
McCarty JM; Grant CK
Cell Immunol; 1983 Oct; 81(1):157-68. PubMed ID: 6311439
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.
Mathes LE; Olsen RG; Hebebrand LC; Hoover EA; Schaller JP; Adams PW; Nichols WS
Cancer Res; 1979 Mar; 39(3):950-5. PubMed ID: 218725
[TBL] [Abstract][Full Text] [Related]
20. Feline oncornavirus-associated cell membrane antigen: evidence for an immunologically crossreactive feline sarcoma virus-coded protein.
Stephenson JR; Khan AS; Sliski AH; Essex M
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5608-12. PubMed ID: 202959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
